Motor neuron diseases are a group of progressive and ultimately fatal neurodegenerative disorders of the motor system, ...

NeuroSense Therapeutics Ltd. ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced the issuance of a pivotal ...

A study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple ...

Researchers have identified biomarkers that can predict disease progression in multiple sclerosis, which could lead to the ...

Across Age and Disability Levels at Baseline For All Progressive Multiple Sclerosis Subtypes – – Preclinical Data Showed Improved Neuronal Survival, Likely Driven by Vidofludimus Calcium's ...

A Potential Neuroprotective Function in Multiple Sclerosis ePoster Number: P1410 Vidofludimus calcium enhanced the expression of Nurr1 target genes important for neuronal survival, such as brain ...

While almost 3 million people worldwide live with multiple sclerosis (MS), many people may not understand the complexity of this unpredictable condition. MS Awareness Month aims to change this and ...

Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that ...

If you've been diagnosed with multiple sclerosis (MS), it's time to start exploring treatment options. You've got a lot of them, everything from disease-modifying therapies and drugs that help manage ...

Medications are the mainstay of treatment for multiple sclerosis (MS). Many of them are used to block the immune system's attack on the nerves and slow or prevent progression and relapses (flare-ups) ...